Order Article Reprints

Struckman NE, de Jong RCM, Honders MW, Smith S-AI, van der Lee DI, Koutsoumpli G, de Ru AH, Mikesch J-H, van Veelen PA, Falkenburg JHF, et al. Hotspot DNA Methyltransferase 3A (DNMT3A) and Isocitrate Dehydrogenase 1 and 2 (IDH1/2) Mutations in Acute Myeloid Leukemia and Their Relevance as Targets for Immunotherapy. Biomedicines. 2024; 12(5):1086. https://doi.org/10.3390/biomedicines12051086

Struckman, Nadine E., Rob C. M. de Jong, M. Willy Honders, Sophie-Anne I. Smith, Dyantha I. van der Lee, Georgia Koutsoumpli, Arnoud H. de Ru, Jan-Henrik Mikesch, Peter A. van Veelen, J. H. Frederik Falkenburg, and et al. 2024. "Hotspot DNA Methyltransferase 3A (DNMT3A) and Isocitrate Dehydrogenase 1 and 2 (IDH1/2) Mutations in Acute Myeloid Leukemia and Their Relevance as Targets for Immunotherapy" Biomedicines 12, no. 5: 1086. https://doi.org/10.3390/biomedicines12051086

Struckman, N. E., de Jong, R. C. M., Honders, M. W., Smith, S. -A. I., van der Lee, D. I., Koutsoumpli, G., de Ru, A. H., Mikesch, J. -H., van Veelen, P. A., Falkenburg, J. H. F., & Griffioen, M. (2024). Hotspot DNA Methyltransferase 3A (DNMT3A) and Isocitrate Dehydrogenase 1 and 2 (IDH1/2) Mutations in Acute Myeloid Leukemia and Their Relevance as Targets for Immunotherapy. Biomedicines, 12(5), 1086. https://doi.org/10.3390/biomedicines12051086